MEDIA ADVISORY: Yale-CURE BioHaven Entrepreneurship Series Presents "Unexpected Outcomes:" A Panel on Navigating Scientific and Management Landmines
The Yale-CURE BioHaven Entrepreneurship Series presents a special panel discussion on Thursday, November 13, from 4 to 5 p.m. in the Anlyan Center Auditorium, 300 Cedar Street. The Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE) organize the entrepreneurial series.
Paul Pescatello, President and CEO of CURE will moderate the discussion “Unexpected Outcomes: Navigating Scientific and Management Landmines.”
Featured speakers will be
- Michael Kishbauch, the president and CEO of Achilleon Pharmaceuticals, Inc.
- Tom Wood, the founding CEO of Applied Spine, Inc.
- Ron Lennox, a partner in CHL Medical Partners
“These seasoned life science entrepreneurs will provide their real world examples of the challenges that inevitably develop for start-up companies,” said to Pescatello. “They will also deconstruct the resolution of obstacles arising in the lab, in the boardroom and with management.”
Refreshments and networking will follow the discussion from 5 to 6 p.m. Registration is free, but advanced registration is required. To register, RSVP to firstname.lastname@example.org or call the Yale Office of Cooperative Research at 203-785-6209. Directions to the event are available online at http://info.med.yale.edu/maps/cab.html
The Yale-CURE BioHaven Entrepreneurship Series is designed to showcase regionally developed life science technologies that have progressed along the path to commercialization. Speakers represent both the scientific and business side of the enterprises, and the programs focus on key success factors of each company, and lessons learned in starting and developing the businesses.
Yale BioHaven Entrepreneurship Series is sponsored by the Yale Office of Cooperative Research, Connecticut United for Research Excellence (CURE), Wiggin and Dana, LLP, Price Waterhouse Coopers, PC and Elm Street Ventures, with support from the Yale Entrepreneurial Institute and the Yale Biotechnology & Pharmaceutical Society.